Displaying items by tag: gregory fleming james cystic fibrosis research center

By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
The CF clinical trials expert will take the reins of the UAB Gregory Fleming James Cystic Fibrosis Center on Aug. 1.